Cohance Lifesciences Ltd

Piramal Pharma Ltd, Kirloskar Oil Engines Ltd, Vedanta Ltd, Neuland Laboratories Ltd are among the other stocks to see a surge in volumes on NSE today, 23 June 2026.Cohance Lifesciences Ltd registered volume of 234.51 lakh shares by 14:14 IST on NSE, a 41.19 fold spurt over two-week average daily volume of 5.69 lakh shares. The stock rose 13.55% to Rs.460.15. Volumes stood at 3.61 lakh shares in the last session.Piramal Pharma Ltd saw volume of 811.88 lakh shares by 14:14 IST on NSE, a 25.97 fold spurt over two-week average daily volume of 31.26 lakh shares. The stock increased 6.43% to Rs.168.70. Volumes stood at 27.1 lakh shares in the last session.Kirloskar Oil Engines Ltd saw volume of 112.23 lakh shares by 14:14 IST on NSE, a 24.16 fold spurt over two-week average daily volume of 4.64 lakh shares. The stock increased 3.75% to Rs.2,479.30. Volumes stood at 17.94 lakh shares in the last session.Vedanta Ltd saw volume of 1586.3 lakh shares by 14:14 IST on NSE, a 8.78 fold spurt over two-week average daily volume of 180.69 lakh shares. The stock dropped 8.34% to Rs.280.35. Volumes stood at 135.51 lakh shares in the last session.Neuland Laboratories Ltd recorded volume of 1.69 lakh shares by 14:14 IST on NSE, a 5.6 times surge over two-week average daily volume of 30124 shares. The stock gained 5.25% to Rs.18,128.00. Volumes stood at 16943 shares in the last session.Powered by Capital Market - Live

Piramal Pharma Ltd, Jain Irrigation Systems Ltd, Aarti Pharmalabs Ltd and BASF India Ltd are among the other gainers in the BSE's 'A' group today, 23 June 2026.Cohance Lifesciences Ltd soared 14.81% to Rs 466.4 at 11:46 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 12.57 lakh shares were traded on the counter so far as against the average daily volumes of 64696 shares in the past one month. Piramal Pharma Ltd spiked 8.26% to Rs 171.75. The stock was the second biggest gainer in 'A' group. On the BSE, 24.21 lakh shares were traded on the counter so far as against the average daily volumes of 3.48 lakh shares in the past one month. Jain Irrigation Systems Ltd surged 6.44% to Rs 37.5. The stock was the third biggest gainer in 'A' group. On the BSE, 7.85 lakh shares were traded on the counter so far as against the average daily volumes of 2.62 lakh shares in the past one month. Aarti Pharmalabs Ltd exploded 6.02% to Rs 718.1. The stock was the fourth biggest gainer in 'A' group. On the BSE, 60419 shares were traded on the counter so far as against the average daily volumes of 12632 shares in the past one month. BASF India Ltd added 5.81% to Rs 3780.4. The stock was the fifth biggest gainer in 'A' group. On the BSE, 5862 shares were traded on the counter so far as against the average daily volumes of 1636 shares in the past one month. Powered by Capital Market - Live

Kirloskar Oil Engines Ltd, Hero MotoCorp Ltd, Physicswallah Ltd, Prestige Estates Projects Ltd are among the other stocks to see a surge in volumes on BSE today, 23 June 2026.Cohance Lifesciences Ltd recorded volume of 9.61 lakh shares by 10:46 IST on BSE, a 12.91 times surge over two-week average daily volume of 74436 shares. The stock gained 17.17% to Rs.476.00. Volumes stood at 13142 shares in the last session.Kirloskar Oil Engines Ltd clocked volume of 6.55 lakh shares by 10:46 IST on BSE, a 6.69 times surge over two-week average daily volume of 97963 shares. The stock gained 5.61% to Rs.2,525.00. Volumes stood at 3.29 lakh shares in the last session.Hero MotoCorp Ltd registered volume of 72816 shares by 10:46 IST on BSE, a 5 fold spurt over two-week average daily volume of 14575 shares. The stock slipped 0.22% to Rs.4,973.90. Volumes stood at 9178 shares in the last session.Physicswallah Ltd witnessed volume of 37.3 lakh shares by 10:46 IST on BSE, a 4.64 times surge over two-week average daily volume of 8.04 lakh shares. The stock increased 1.82% to Rs.128.40. Volumes stood at 27.35 lakh shares in the last session.Prestige Estates Projects Ltd registered volume of 1.59 lakh shares by 10:46 IST on BSE, a 3.56 fold spurt over two-week average daily volume of 44636 shares. The stock rose 3.58% to Rs.1,566.20. Volumes stood at 1.02 lakh shares in the last session.Powered by Capital Market - Live

According to the company's regulatory filing, Agarwal will be relieved from his duties with effect from the close of business hours on September 13, 2026. Agarwal served as a whole-time director and key managerial personnel (KMP) of the company. The resignation is not linked to any material concerns and has been submitted to enable him to pursue opportunities outside the organisation. The company has not yet announced a successor for the CFO role. Cohance Lifesciences, formerly Suven Pharmaceuticals, is an innovator-focused global CRDMO formed through the merger of Cohance Life Sciences into Suven Pharmaceuticals. It is a technology-driven, integrated CDMO platform offering development and manufacturing solutions across complex APIs, performance materials, agrochemicals, ADCs, oligonucleotides and advanced chemistries for global pharmaceutical and life sciences customers. The company's consolidated net profit tanked 66.8% to Rs 44.67 crore on 26.2% decline in revenue from operations to Rs 567.55 crore in Q4 FY26 over Q4 FY25. The scrip declined 2.42% to end at Rs 415.55 on the BSE. Powered by Capital Market - Live

Net profit of Cohance Lifesciences declined 83.77% to Rs 19.55 crore in the quarter ended March 2026 as against Rs 120.43 crore during the previous quarter ended March 2025. Sales declined 26.33% to Rs 619.12 crore in the quarter ended March 2026 as against Rs 840.42 crore during the previous quarter ended March 2025. For the full year,net profit declined 63.22% to Rs 179.23 crore in the year ended March 2026 as against Rs 487.34 crore during the previous year ended March 2025. Sales declined 13.03% to Rs 2268.55 crore in the year ended March 2026 as against Rs 2608.50 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales619.12840.42 -26 2268.552608.50 -13 OPM %15.9427.27 -18.8230.56 - PBDT87.65230.82 -62 423.84825.21 -49 PBT36.42176.65 -79 236.51658.41 -64 NP19.55120.43 -84 179.23487.34 -63 Powered by Capital Market - Live

Cohance Lifesciences will hold a meeting of the Board of Directors of the Company on 12 May 2026.

AGI Greenpac Ltd, Black Box Ltd, Electronics Mart India Ltd and Epack Durable Ltd are among the other gainers in the BSE's 'A' group today, 28 April 2026.Cohance Lifesciences Ltd surged 15.30% to Rs 498.9 at 11:47 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 20.16 lakh shares were traded on the counter so far as against the average daily volumes of 5.45 lakh shares in the past one month. AGI Greenpac Ltd spiked 12.13% to Rs 633.05. The stock was the second biggest gainer in 'A' group. On the BSE, 2.77 lakh shares were traded on the counter so far as against the average daily volumes of 15484 shares in the past one month. Black Box Ltd soared 10.24% to Rs 638.75. The stock was the third biggest gainer in 'A' group. On the BSE, 1.94 lakh shares were traded on the counter so far as against the average daily volumes of 20649 shares in the past one month. Electronics Mart India Ltd added 10.00% to Rs 121.5. The stock was the fourth biggest gainer in 'A' group. On the BSE, 2.01 lakh shares were traded on the counter so far as against the average daily volumes of 33506 shares in the past one month. Epack Durable Ltd exploded 8.58% to Rs 292.85. The stock was the fifth biggest gainer in 'A' group. On the BSE, 15.37 lakh shares were traded on the counter so far as against the average daily volumes of 68544 shares in the past one month.

India Cements Ltd, Tanla Platforms Ltd, Blue Jet Healthcare Ltd and Epack Durable Ltd are among the other gainers in the BSE's 'A' group today, 27 April 2026.Cohance Lifesciences Ltd soared 19.99% to Rs 432.7 at 11:47 IST. The stock was the biggest gainer in the BSE's 'A' group. On the BSE, 15.19 lakh shares were traded on the counter so far as against the average daily volumes of 4.86 lakh shares in the past one month. India Cements Ltd surged 12.10% to Rs 457.05. The stock was the second biggest gainer in 'A' group. On the BSE, 6.92 lakh shares were traded on the counter so far as against the average daily volumes of 10613 shares in the past one month. Tanla Platforms Ltd spiked 11.33% to Rs 541.5. The stock was the third biggest gainer in 'A' group. On the BSE, 4.43 lakh shares were traded on the counter so far as against the average daily volumes of 38325 shares in the past one month. Blue Jet Healthcare Ltd exploded 9.99% to Rs 443.75. The stock was the fourth biggest gainer in 'A' group. On the BSE, 1.05 lakh shares were traded on the counter so far as against the average daily volumes of 27090 shares in the past one month. Epack Durable Ltd rose 8.63% to Rs 253.1. The stock was the fifth biggest gainer in 'A' group. On the BSE, 52724 shares were traded on the counter so far as against the average daily volumes of 37732 shares in the past one month.

Vohra will succeed Vivek Sharma, who is stepping down as executive chairman for personal reasons. Sharma will continue with Cohance as an advisor for the next nine months to ensure a smooth transition. Vohra is one of the most accomplished leaders in the pharmaceutical industry. Over a career spanning more than three decades, he has led large, complex, global businesses through periods of strategic transformation while maintaining an unwavering focus on customers, quality and operational excellence. Most recently, as CEO and managing director of Cipla, Vohra led the company's transformation over the last decade to build a diversified global pharmaceutical enterprise. Having worked in and transformed two very large and respected Pharma companies in India, Vohra brings an owner-mindset and vast experience in business to the Cohance platform. The company said the appointment reflects a deliberate, strategic decision taken by the board, to bring in a leader whose profile is specifically suited to the demands of Cohance's transformation and its next phase of growth. Commenting on appointment, Umang Vohra said, 'I am very excited to be joining Cohance. I believe deeply in the long-term value creation potential of this platform. Cohance's technology offerings, depth of its R&D talent, and the quality of the leadership team already in place provide a strong foundation. I am looking forward to this entrepreneurial stint and will work closely with the current management leaders to create value for customers, employees and shareholders alike. Cohance Lifesciences, formerly Suven Pharmaceuticals, is an innovator-focused global CRDMO formed through the merger of Cohance Life Sciences into Suven Pharmaceuticals. It is a technology-driven, integrated CDMO platform offering development and manufacturing solutions across complex APIs, performance materials, agrochemicals, ADCs, oligonucleotides and advanced chemistries for global pharmaceutical and life sciences customers. The company's consolidated net profit dropped 76% to Rs 36.72 crore on 19.5% decline in revenue from operations to Rs 544.55 crore in Q3 FY26 over Q3 FY25.

The board of Cohance Lifesciences at its meeting held on 27 April 2026 has approved the following: Noted the resignation of Vivek Sharma (DIN 08559495), as Executive Chairman and director of the Company with effect from 30 April 2026. Approved the appointment of Umang Vohra as Additional Director, designated as Chairman, and Group Chief Executive Officer with effect from 01 May 2026 and 20 May 2026 respectively.